Spectrophotometric and TLC-densitometric methods for the simultaneous determination of Ezetimibe and Atorvastatin calcium

Three sensitive methods were developed for simultaneous determination of Ezetimibe (EZB) and Atorvastatin calcium (ATVC) in binary mixtures. First derivative (D1) spectrophotometry was employed for simultaneous determination of EZB (223.8nm) and ATVC (233.0nm) with a mean percentage recovery of 100....

Full description

Saved in:
Bibliographic Details
Published inJournal of advanced research Vol. 4; no. 1; pp. 51 - 59
Main Authors Baghdady, Yehia Z., Al-Ghobashy, Medhat A., Abdel-Aleem, Abdel-Aziz E., Weshahy, Soheir A.
Format Journal Article
LanguageEnglish
Published Egypt Elsevier B.V 01.01.2013
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Three sensitive methods were developed for simultaneous determination of Ezetimibe (EZB) and Atorvastatin calcium (ATVC) in binary mixtures. First derivative (D1) spectrophotometry was employed for simultaneous determination of EZB (223.8nm) and ATVC (233.0nm) with a mean percentage recovery of 100.23±1.62 and 99.58±0.84, respectively. Linearity ranges were 10.00–30.00μgmL−1 and 10.00–35.00μgmL−1, respectively. Isosbestic point (IS) spectrophotometry, in conjunction with second derivative (D2) spectrophotometry was employed for analysis of the same mixture. Total concentration was determined at IS, 224.6nm and 238.6nm over a concentration range of 10.00–35.00μgmL−1 and 5.00–30.00μgmL−1, respectively. ATVC concentration was determined using D2 at 313.0nm (10.00–35.00μgmL−1) with a mean recovery percentage of 99.72±1.36, while EZB was determined mathematically at 224.6nm (99.75±1.43) and 238.6nm (99.80±0.95). TLC-densitometry was employed for the determination of the same mixture; 0.10–0.60μgband−1 for both drugs. Separation was carried out on silica gel plates using diethyl ether–ethyl acetate (7:3v/v). EZB and ATVC were resolved with Rf values of 0.78 and 0.13. Determination was carried out at 254.0nm with a mean percentage recovery of 99.77±1.30 and 99.86±0.97, respectively. Methods were validated according to ICH guidelines and successfully applied for analysis of bulk powder and pharmaceutical formulations. Results were statistically compared to a reported method and no significant difference was noticed regarding accuracy and precision.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2090-1232
2090-1224
DOI:10.1016/j.jare.2012.01.003